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The infection of the mouse with murine cytomegalovirus (MCMV)' serves as
a model to study the biology of CMV infection. Similar to the situation in the
immunocompromised patient after infection with human CMV (HCMV), im-
munodeficient mice develop interstitial pneumonia and succumb to generalized
MCMV infection (1). Immunocompetent mice generate specific cytolytic T
lymphocytes (CTL) (2) and prophylactic as well as therapeutic adoptive transfer
of CTL into immunodeficient recipients limits viral spread in tissues and protects
mice from fatal disease (1, 3).
We wish to define the antigens detected by protective CTL and the genes
encoding them. As in other herpesviruses, MCMV is expressed in three sequential
phases, immediate-early (IE), early, and late, which show coordinate regulation
and temporal control (4). IE genes are the first viral genes expressed after
infection, and IE proteins are required for the induction ofearly gene expression .
CTL recognize at least one membrane antigen expressed already during the IE
phase of infection (5). These IE-specific CTL comprise the majority of MCMV-
specific CTL (6). Within the 235 kbp double-stranded linear DNA of the MCMV
genome (7), abundant IE transcription originates from a region of ^-12 kbp
containing three transcription units: iel, 10, and ie3 (4, 8). Transcription unit
ie l is predominantly transcribed, and proteins encoded by this unit have a
function in transcriptional activation (9, 10).
Transfection of the complete IE region or of the isolated transcription unit
iel leads to antigen expression in transfected cells detected by IE-specific CTL
(11, 12). Several differently spliced mRNAs are transcribed from ie 1 . A 2.75 kb
mRNA transcribed from gene ieI contained in transcription unit 1 is translated
into a nonstructural phosphoprotein of 89 kD, the major MCMV IE protein
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￿
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pp89. Additional smaller ie l products, which are antigenically related to pp89,
range in size from 31 to 67,000 kD (8). Gene ieI has been sequenced, and after
mapping of exons, an open reading frame has been deduced (13). To prove the
identity of the deduced ieI product with pp89 and to test whether the major IE
protein is processed to a membrane antigen recognized by IE-specific CTL, we
turned to the selective expression of gene ieI in eukaryotic cells. Here we report
on the construction of the continuous coding sequence of ieI by oligonucleotide-
directed mutagenesis, its integration into a vaccinia virus (VAC) vector, and on
some biological properties of the resulting MCMV-ieI-VAC recombinant.
Materials and Methods
Site-directed Mutagenesis and Construction ofVAC Recombinants.
￿
The 1 .5 kb Hind III-
Sac I fragment of gene ieI, containing the 3' splice site of intron 1 and the introns 2 and
3, was cloned into M13mp19 for mutagenesis. Oligonucleotide-directed mutagenesis was
performed according to a protocol by Zoller and Smith (14). 10 pmols of kinase-treated
mutagenic primer were added to 1 kg of single-stranded template DNA in 10 kl TM-
buffer (10 mM Tris HCI, pH 8, 10 MM MgCl2), incubated at 80°C, and allowed to cool
down to room temperature for annealing. The annealed mixture was adjusted to a 20 A,1
volume of 10 mM Tris HCI, pH 8, 10 MM MgCl2, 250 pM dNTPs, 250 bLM rATP, and
5 uM dithiothreitol. After addition of 10 U ligase (Boehringer Biochemicals, Mannheim,
Federal Republic of Germany) and 1 U Klenow fragment of DNA polymerase (Bethesda
Research Laboratories, Gaithersburg, MD), the sample was incubated overnight at 12°C
for primer extension . The mixture was used for transformation of BMH 71-18 mut
(mutator) L cells (15). BMH 71-18 (15) provided the feeder lawn, to minimize undesired
mutagenesis by the transformed mutator strain . Plaques were picked and grown on LB
agar plates (Difco Laboratories, Detroit, MI). The colonies were transferred to nitrocel-
lulose filters and screened for mutagenized clones by hybridization using the end-labeled
mutagenic oligonucleotides. Finally, the resulting mutagenesis was controlled by sequenc-
ing of DNA from the plaque-purified clones. The open reading frame of ieI was cloned
into the Eco RI site of the VAC recombination vector pGS62 (16). Construction of
recombinant VAC followed established procedures (17, 18) using the VAC strain WR
and the temperature-sensitive mutant is 7 of the VAC strain Copenhagen (19-21).
Immunoprecipitation.
￿
Protein extracts were prepared of cells labeled with 100 ACi
[3r'S]methionine for 2 h in methionine-free DMEM and solubilized in lysis buffer (10 mM
Tris HCI, pH 7 .6, 1 % NP-40, 1 % sodium deoxycholate, 0 .1 % SDS, 1 mg/ml ovalbumin,
1 mM methionine, 1 mM phenylmethylsulfonyl fluoride). IE protein was precipitated with
murine antiserum to MCMV. SDS gel electrophoresis was carried out as previously
described (9).
Generation of Cytolytic Effector Cells.
￿
For polyclonal CTL, splenocytes and mesenteric
lymph node cells were obtained from BALB/c mice 2 wk after intravenous immunization
with 2 x 10' PFU of the VAC recombinant or of wild-type VAC. Lymphocytes (4 x 106
in 2 ml cultures) were restimulated in vitro for 5 d using 106 PFU of live MCMV per
culture (strain Smith, VR-194 ; American Type Culture Collection, Rockville, MD) as
antigen (2, 22).
Expression of MCMV IE membrane antigen was tested with CTL clone IE1, line 1 .18-
IL (22-24). This line was maintained in IL-2-supplemented medium without antigen.
Target Cells and Cytolytic Assay.
￿
The following target cells were used: (a) BALB/c
mouse embryo fibroblasts (MEF). MEF were infected with MCMV under conditions that
provided selective expression of IE genes as described before (4-6, 9). (b) Ltk- (C3H/An
origin, haplotype H-2') cells transfected with the H-2Ld gene (line L/Ld) or cotransfected
with H-2Ld and MCMV iel (line L/ieI-Ld/2) (12) . (c) L/Ld cells infected with MCMV-ieI-
VAC or wild-type VAC . L cells were infected at a multiplicity of infection of 5 to 10 with
wild-type VAC or with recombinant VAC 18 h before testing in the cytolytic assay.
A standard 3-h CTL assay was used (6, 22-24). In brief, 103 "Cr-labeled target cells670 NONSTRUCTURAL HERPESVIRUS PROTEIN RECOGNIZED BY T CELLS
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Alteration of gene ieI structure . Gene ieI was modified as described in Materials
and Methods . The structural organization of the iel gene in the MCMV genome is depicted
at the top . The coding sequences of exons are indicated by black bars . The location of the
upstream MCMV enhancer (25) is indicated by an open box . The distance (in base pairs) from
the transcription start site and the positions of exons, introns, and some cleavage sites are
indicated . Mutagenesis was performed in three sequential steps shown below : First, intron 2
and then intron 3 were removed by using oligonucleotides comprising the flanking exon
sequences of the respective intron . The following 20-mers were used for deletion : Intron 2,
5'-CAT CAG ACA AGG TGC CAG CT-3' ; intron 3, 5'-CAT GCT GCA GTG AGG AGC
GT-3' . The 26-mer 5'-TGA TGA TAA AQA ATT _CTA TTT TTT TA-3', with the
mismatches underlined, was used to introduce a new Eco RI site 22 by upstream of the
initiation codon by a two-basepair exchange. The restructured continuous coding sequence of
iel, consisting of the mutagenized fragment (black bar) joined to the nonmutagenized large
fragment of exon 4 (open bar), flanked by Eco RI sites, is shown at the bottom .
per well were added to the effector cells in 96-well tissue culture plates . The E/T ratio
ranged from 3 :1 to 50:1 for polyclonal CTL, and from 0.7:1 to 25 :1 for the IE-specific
CTL clone . Data are expressed as the mean percent specific lysis offour replicate cultures .
Construction of a Recombinant VAC Containing the pp89 Open Reading
Frame . The gene ieI encoding the major IF protein pp89 has a four-exon
structure (13) (Fig . 1) . The initiation codon of the pp89 open reading frame
(orf) is located at position 1,130 in the second exon . Interrupted twice by introns
2 and 3, it is terminated at position 3,134 in the fourth exon . For selective
expression of the pp89 orf in VAC, we had to construct the continuous pp89
coding sequence without introns . The introns 2 and 3 were removed by site-
directed mutagenesis . To this end, the Hind III-Sac I fragment, which contains
the 3' splice acceptor site of intron 1, the introns and exons 2 and 3, and a
fragment of exon 4, was cloned into MI3mp19 . Single-stranded template DNA
was isolated, and the orf was restructured by sequential excision of the introns 2
and 3 . In addition, an Eco RI site was created 22 by upstream of the initiation
codon . The Eco RV fragment, which contained the mutagenized regions, was
sequenced and then cloned into the Eco RV site of the 2 kb Ava I fragment
encompassing the complete fourth exon . The 5' Ava I site is located in the third
exon, and the 3' Ava I site is at position 3,349 . Before, the Ava I fragment wasVOLKMER ET AL .
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FIGURE 2. Immunoprecipitation of proteins
synthesized after infection with MCMV-iel-
VAC. Lane 1, MEF infected withMCMV ; lanes
2-6, L/Ld cells infected with MCMV-ieI-VAC
for 6, 8, 10, 14, and 16 h; lane 7, L/Ld cells
infected with wild-type VAC; lane 8, mock-
infected L/Ld cells ; M, marker lane . Markers
were myosin, 200 ; phosphorylase, 92 .5 ; BSA,
69 ; and ovalbumin, 46 kD . Cells were infected
at a multiplicity of infection of 20, and were
labeled 2 hbefore the preparation of lysates.
filled up to blunt ends and cloned into the Sma I site ofpUC12 in the orientation
that placed the Eco RI site of the polylinker at the end of the fourth exon of ieI .
After insertion of the mutagenized Eco RV fragment, the restructured intron-
free gene ieI was now flanked by two Eco RI sites : a polylinker Eco RI site at the
3' end, and a new Eco RI site introduced by site-directed mutagenesis 5' of the
orf. This Eco RI fragment was cloned into the Eco RI site ofpGS62 downstream
ofthe P7.5 VAC promoter . This construct (pGS62-pp89-orf) was used to prepare
a recombinant VAC.
Expression ofpp89 in Recombinant VAC .
￿
Infection of MEF and of L cells with
the isolated recombinant (MCMV-ieI-VAC) resulted in expression of nuclear
antigen detected by immunofluorescence using monoclonal antibody specific for
pp89 (9, 10), while cells infected with wild-type VAC showed no fluorescence
(not shown) . The size of the polypeptide expressed in MCMV-ie7-VAC-infected
cells was determined by immunoprecipitation (Fig . 2) . Murine antiserum to
MCMV precipitated a polypeptide migrating at theposition of89 kD . In addition,
a band was seen that migrated with an M, of 76,000 . The relative molecular
masses of the larger and the smaller protein correspond to the size ofMCMV
pp89 and its 76,000 Mr derivative, a posttranslational modification product (9) .
Thus, the results demonstrated that pp89 was correctly expressed by the VAC
vectorand that the polypeptide was properly modified and correctly transported
to the cell nucleus . Despite that the P7 .5 promoter of VAC is active at both,
early and late times of infection, the kinetics of polypeptide synthesis showed
that efficient pp89 expression in MCMV-ieI-VAC occurred mainly at the late
stage of VAC replication .
CTL Recognition of Antigens Induced by MCMV-ieI-VAC .
￿
The CTL clone IE1
detects an antigen expressed at IE times of infection in association with theMHC
class I molecule Ld (11, 22-24) . After transfection of transcription unit 1 into L
cells, the epitope recognized by this CTL clone is detectable (12) . This CTL
clone was now used to test L/Ld cells after infection with MCMV-ieI-VAC for
expression of the epitope (Fig . 3) . The specific cytolytic activity of theCTL clone
IE1 is demonstrated by lysis of line L/iel-Ld/2 expressing both, H-2Ld and
products of transcription unit iel ofMCMV (Fig . 3, /) . L/Ld cells infected with
wild-type VAC (Fig. 3, O) and mock infected cells (p) were not lysed. Specific
lysis of L/Ld cells infected with the MCMV-ieI-VAC (40) was comparable to that67 2 NONSTRUCTURAL HERPESVIRUS PROTEIN RECOGNIZED BV T CELLS
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FIGURE 3. Lysis of MCMV-ieI-VAC-infected cells by cloned
CTL. Noninfected (p) L/Ld cells or cells infected with either
recombinant MCMV-ieI-VAC (40) or wild-type VAC (Q) at a multi-
plicity of infection of 5-10 were used. After 18 h incubation, the
cells were labeled for 1.5 h with 5'Cr and dispensed into 96-well
microtiter dates(1Oscells/well) containinggraded numbersofCTL
cloneIE1. 'Cr-labeled L/iel-L'/2 cellsserved as control target for
the detectionof the IE1 epitope (/).
of L/ieI-Ld/2 . MCMV-ieI-VAC-infected L cells that lacked Ld were not recog-
nized (not shown). Thus, pp89, the product of the ieI gene in transcription unit
1, provides the epitope recognized by the CTL clone IE1 .
Recombinant VAC Primes for pp89-specific CTL.
￿
BALB/c mice were infected
with either wild-type or recombinant VAC. At day 14, cells from the spleen and
lymph nodes were restimulated with MCMV in vitro. The secondary polyclonal
CTL response was tested 5 d later (Fig. 4). CTL from MCMV-ieI-VAC-primed
mice were able to lyse syngeneic MCMV-infected fibroblasts selectively express-
ing IE gene products after MCMV infection (IE-MEF), L/Ld cells infected with
MCMV-ieI-VAC, and also line L/iel-Ld/2 (Fig. 4, top row, 0). IE antigen
expression in target cells is usually low, and specific lysis, even when the cloned
CTL line is used rarely exceeds 40%. In the experiment shown, the lytic activity
of MCMV-ieI-VAC-primed polyclonal CTL on target cells expressing the ieI
gene was comparable to that of the cloned CTL line. Uninfected MEF, wild-type
VAC-infected L/Ld cells, and noninfected L/Ld cells were not recognized,
demonstrating the specificity of the CTL activity (Fig. 4, bottom row, ").
Lymphocytes from wild-type VAC-sensitized mice restimulated in vitro with
MCMV failed to lyse any of the target cells (O). MCMV-ieI-VAC- and wild-type
VAC-primed mice generated VAC-specific CTL after restimulation with VAC
(not shown) .
Discussion
In our previous studies on MCMV IE antigen recognition by CTL (5, 6, 11,
22-24), we detected that nonstructural viral IE proteins (7-10) serve as dominant
target antigens for the cellular immune response. In further studies, we were
able to associate IF antigen expression detected by CTL with the expression of
transcription unit ieI (12).
Because transcripts from ie 1 are differently spliced and translated into proteins
of different size, results obtained by transfection of MCMV DNA sequences
could not identify the gene product of ie I that leads to the expression of a target
antigen. We have analyzed the structural organization and the sequence of the
dominantly expressed gene ieI in transcription unit ieI that gives rise to the 2.75
kb mRNA translated into pp89 (13) . Based on this analysis, the ieI coding region
was restructured by site-directed mutagenesis. This strategy was preferred to' 'A
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FIGURE 4.
￿
Priming for an iel-specific CTL response by MCMV-ieI-VAC . Splenocytes and
lymph node cells were obtained from BALB/c mice 2 wk after intravenous infection with 2 X
10' plaque-forming units of MCMV-ieI-VAC (0) or wild-type VAC (O). After restimulation in
vitro with MCMV for 5 d, CTL activity and specificity was determined . Target cells used :
BALB/c MET, infected with MCMV in the presence of cycloheximide (50,ug/ml), which was
replaced after 3 h by actinomycin D (5 rug/ml) to achieve selective and enhanced synthesis of
IF proteins (IE-MEF), or noninfected cells (MEF); L/Ld cells infected with the VAC recombi-
nant (MCMV-ieI-VAC) or infected with wild-type VAC (VAC) . L cells doubly transfected with
Ld and MCMV-ieI (L/iel-L'/2) and L cells expressing only the Ld molecule (L/L') . In this
experiment, specific lysis by CTL clone IF I (E/T ratio 20:1) of MCMV-ieI-VAC-infected
L/Ld cells was 20% .
cDNA cloning, because at the IE stage of infection a second 2.75 kb RNA is
transcribed, which shares coding regions with the mRNA encoding pp89 but
terminates downstream in transcription unit ie3 (8). The intron-free continuous
coding sequence of the ieI gene in the VAC recombinant encoded a protein
indistinguishable from pp89 with regard to size, posttranslational processing,
and intracellular transport, thereby confirming the data on the structural orga-
nization of ieI (13) . Thus, the VAC system could be used to selectively express a
single gene product from a complex transcription unit and to test some of its
properties .
The formal proof for our previous postulate (6) that the dominant nonstruc-
tural, regulatory IE protein of MCMV, pp89, gives rise to a CTL response and
is detected by CTL after infection of cells, represents the important information
ofthis contribution . Although new fora herpesvirus, the recognition of nonstruc-
tural viral proteins by CTL is, however, not without precedent . Murine CTL
can recognize the nonstructural large T antigen in SV-40-transformed murine
cells (26), and recently it was reported that CTL can detect the nonstructural
NS1 protein of influenza virus (27) . The mechanism by which proteins that lack674 NONSTRUCTURAL HERPESVIRUS PROTEIN RECOGNIZED BY T CELLS
signal sequences for transport to the plasma membrane and that do not possess
transmembrane domains are presented to serve as antigens forCTL is a matter
of current investigation. There is some evidence for intracellular protein degra-
dation and membrane presentation of peptides in association with class I gene
products (28, 29) . Our finding that a monoclonal antibody that detects a
sequential epitope in the pp89 molecule fails to detect the antigen at the plasma
membrane (our unpublished observation) also suggests fragmentation of pp89 .
The possible role for glycoproteins in immunity to herpesvirus has been
demonstrated by the biological activity of recombinant VAC expressing herpes
simplex virus type I glycoprotein D (30, 31) . Expression of virus-encoded proteins
that do not contribute to the virion structure is restricted to cells infected with
live virus . The fact that nonstructural proteins are also detected by CTL could
offer, among other arguments, an explanation for the well-known superior
efficiency of live over inactivated vaccines . Because the MHC-restricted function
ofCTL in principle prevents detection of free virions, the recognition of viral
structural proteins byCTLalso requires cell membrane expression of the antigen .
Therefore, it should make no fundamental difference for thepotential protective
function of a CTL clone whether it detects a structural or a nonstructural viral
polypeptide . Demonstration ofCTL with specificity for a nonstructural protein
does not predict whether such CTL contribute to protection or cause immuno-
pathology. For the MCMV model, our results indicate so far that CTL popula-
tions enriched for CTL with selective specificity for IE antigen(s) can have
protective effects in vivo (32) . These findings did not allow us to conclude which
of the IE proteins contributes to protective immunity . The VAC recombinant
containing the ieI gene now provides for the first time the possibility of testing
the in vivo function ofCTL sensitized against a single herpesviral IE protein .
TheMHC class I genes have an immune response gene function in dictating
the restriction specificity of virus-specific CTL and determining the responder
phenotype of a given mouse strain . For certain virus models, a nonresponder or
low responder status has been described that reflects either the complete inability
to generate specific CTL or the inability to generate CTL that recognize viral
antigens in association with the nonresponder allelic form of one of the three
class I molecules (reviewed in 33 and 34). Cytomegaloviruses have very large
genomes and the highest potential coding capacity of all known animal viruses .
Because MCMV is a natural pathogen of the mouse, it is questionable whether
mouse strains that are total nonresponders to this virus exist at all . This may be
different with regard to the response to single gene products expressed by
genetically engineered recombinant vaccines . Such information is relevant for
the design of vaccines . In the BALB/c strain (haplotype H-2d), which was mainly
used in our studies so far, at least a substantial fraction of CTL recognize
products encodedby transcription unit ie 1 in association with the H-2Ld molecule
(12) . Further experiments using theVAC recombinant will show whether vacci-
nation with MCMV-ieI-VAC can protect mice against the challenge with a lethal
dose ofMCMV and whether this effect is restricted to certain MHC haplotypes .VOLKMER ET AL .
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Summary
The murine immediate-early (IE) protein pp89 is a nonstructural virus-en-
coded phosphoprotein residing in the nucleus of infected cells, where it acts as
transcriptional activator . Frequency analysis has shown that in BALB/c mice the
majority of virus-specific CTL recognize IE antigens . The present study was
performed to assess whether pp89 causes membrane antigen expression detected
by IE-specific CTL . Site-directed mutagenesis has been used to delete the introns
from gene ieI, encoding pp89, for subsequent integration of the continuous
coding sequence into the vaccinia virus genome. After infection with the vaccinia
recombinant, the authentic pp89 was expressed in cells that became susceptible
to lysis by an IE-specific CTL clone . Priming ofmice with the vaccinia recombi-
nant sensitized polyclonal CTL that recognized MCMV-infected cells and trans-
fected cells expressing pp89 . Thus, a herpesviral IE polypeptide with essential
function in viral transcriptional regulation can also serve as a dominant antigen
for the specific CTL response of the host .
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